 |
|
Genetic Risk Prediction for Normal-Karyotype Acute Myeloid Leukemia Using Whole-Exome Sequencing
Seong Gu Heo, Eun Pyo Hong, Ji Wan Park
Genomics Inform. 2013;11(1):46-51. Published online 2013 Mar 31 DOI: https://doi.org/10.5808/GI.2013.11.1.46
|
|
Citations to this article as recorded by
 Prognostic value of bone marrow MUC4 expression in acute myeloid leukaemia
AS Abdelhady, FF Abdel Hamid, NM Hassan, DM Ibrahim
British Journal of Biomedical Science.2020; 77(4): 202. CrossRef Genomic data integration in chronic lymphocytic leukemia
Juan Luis Fernández‐Martínez, Enrique J. deAndrés‐Galiana, Stephen T. Sonis
The Journal of Gene Medicine.2017;[Epub] CrossRef Identification of somatic mutations using whole-exome sequencing in Korean patients with acute myeloid leukemia
Seong Gu Heo, Youngil Koh, Jong Kwang Kim, Jongsun Jung, Hyung-Lae Kim, Sung-Soo Yoon, Ji Wan Park
BMC Medical Genetics.2017;[Epub] CrossRef Content Analysis of Informed Consent for Whole Genome Sequencing Offered by Direct-to-Consumer Genetic Testing Companies
Emilia Niemiec, Pascal Borry, Wim Pinxten, Heidi Carmen Howard
Human Mutation.2016; 37(12): 1248. CrossRef Class III Receptor Tyrosine Kinases in Acute Leukemia – Biological Functions and Modern Laboratory Analysis
Rimma Berenstein
Biomarker Insights.2015; 10s3: BMI.S22433. CrossRef XPD gene polymorphisms and the effects of induction chemotherapy in cytogenetically normal de novo acute myeloid leukemia patients
Mervat A. El-Tokhy, Neveen A. Hussein, Ahmed M. L. Bedewy, Mohammad R. Barakat
Hematology.2014; 19(7): 397. CrossRef
|